Apotheken
|
Doctor
|
Drugs
|
Hospital
|
Interactions
|
MiGeL
|
Registration owner
|
Services
Recent Registrations
Price comparison
Price comparison and Component
Brand name
Component
Registration owner
Indication
Interaction
Unwanted Effect
Swissmedic-# (5-digit)
Pharmacode
Product
Package Size
EFP
CP
SB
DC
Composition
Registr. Holder
Category
January
-
February
-
March
-
April
- May -
June
-
July
-
August
-
September
-
Oktober
-
November
-
December
|
2002
-
2003
-
2004
-
2005
-
2006
-
2007
-
2008
-
2009
-
2010
-
2011
-
2012
-
2013
-
2014
-
2015
-
2016
-
2017
-
2018
- 2019 -
2020
-
2021
-
2022
-
2023
-
2024
-
2025
May 2019 - 48 products
IP
Escitalopram Sandoz 10 mg
14
5.61
15.30
10 %
Melting tablets: Escitalopramum 10 mg
Sandoz
Pharmaceuticals AG
B / SL / SG
FB
G
IP
Escitalopram Sandoz 10 mg
30
10.55
27.85
10 %
Melting tablets: Escitalopramum 10 mg
Sandoz
Pharmaceuticals AG
B / SL / SG
FB
G
IP
Escitalopram Sandoz 10 mg
60
19.68
37.80
10 %
Melting tablets: Escitalopramum 10 mg
Sandoz
Pharmaceuticals AG
B / SL / SG
FB
G
IP
Escitalopram Sandoz 20 mg
30
19.68
37.80
10 %
Melting tablets: Escitalopramum 20 mg
Sandoz
Pharmaceuticals AG
B / SL / SG
FB
G
IP
Escitalopram Sandoz 20 mg
60
39.35
59.20
10 %
Melting tablets: Escitalopramum 20 mg
Sandoz
Pharmaceuticals AG
B / SL / SG
FB
G
IP
Zoledronat Accord onco 4
mg/5 ml
105.85
131.55
10 %
Concentrate for infusion: Acidum Zoledronicum 4mg / 5ml
Accord Healthcare AG
B / SL / SG
FB
G
IP
CI
Methylphenidat-Mepha LA
10mg
30
13.21
30.80
10 %
Delayed release capsules: Methylphenidati Hydrochloridum 10 mg
Mepha Pharma AG
A+ / SL / SG
FB
G
IP
CI
Methylphenidat-Mepha LA
10mg
100
37.42
57.10
10 %
Delayed release capsules: Methylphenidati Hydrochloridum 10 mg
Mepha Pharma AG
A+ / SL / SG
FB
G
IP
CI
Methylphenidat-Mepha LA
20mg
30
26.42
45.15
10 %
Delayed release capsules: Methylphenidati Hydrochloridum 20 mg
Mepha Pharma AG
A+ / SL / SG
FB
G
IP
CI
Methylphenidat-Mepha LA
20mg
100
74.84
97.80
10 %
Delayed release capsules: Methylphenidati Hydrochloridum 20 mg
Mepha Pharma AG
A+ / SL / SG
FB
G
IP
CI
Methylphenidat-Mepha LA
30mg
30
34.31
53.75
10 %
Delayed release capsules: Methylphenidati Hydrochloridum 30 mg
Mepha Pharma AG
A+ / SL / SG
FB
G
IP
CI
Methylphenidat-Mepha LA
30mg
100
97.22
122.15
10 %
Delayed release capsules: Methylphenidati Hydrochloridum 30 mg
Mepha Pharma AG
A+ / SL / SG
FB
G
IP
CI
Methylphenidat-Mepha LA
40mg
30
39.62
59.50
10 %
Delayed release capsules: Methylphenidati Hydrochloridum 40 mg
Mepha Pharma AG
A+ / SL / SG
FB
G
IP
CI
Methylphenidat-Mepha LA
40mg
100
112.27
138.50
10 %
Delayed release capsules: Methylphenidati Hydrochloridum 40 mg
Mepha Pharma AG
A+ / SL / SG
FB
G
L
IP
CI
Dasatinib-Teva 20 mg
60
484.40
543.25
10 %
Coated tablets: Dasatinibum 20 mg
Teva Pharma AG
A / SL / SG
FB
G
L
IP
Dasatinib-Teva 50 mg
60
1072.75
1183.10
10 %
Coated tablets: Dasatinibum 50 mg
Teva Pharma AG
A / SL / SG
FB
G
L
IP
Dasatinib-Teva 70 mg
60
1072.75
1183.10
10 %
Coated tablets: Dasatinibum 70 mg
Teva Pharma AG
A / SL / SG
FB
G
L
IP
Dasatinib-Teva 100 mg
30
1102.52
1215.45
10 %
Coated tablets: Dasatinibum 100 mg
Teva Pharma AG
A / SL / SG
FB
G
L
IP
Accofil 300mcg/0.5ml
57.43
78.85
10 %
Injection solution in prefilled syringe: Filgrastimum 30Mio. U. / 0.5ml
Accord Healthcare AG
A / SL
FB
G
L
IP
Accofil 300mcg/0.5ml
5
293.98
335.45
10 %
Injection solution in prefilled syringe: Filgrastimum 30Mio. U. / 0.5ml
Accord Healthcare AG
A / SL
FB
G
L
IP
Accofil 480mcg/0.5ml
82.76
106.40
10 %
Injection solution in prefilled syringe: Filgrastimum 48Mio. U. / 0.5ml
Accord Healthcare AG
A / SL
FB
G
L
IP
Accofil 480mcg/0.5ml
5
413.82
465.50
10 %
Injection solution in prefilled syringe: Filgrastimum 48Mio. U. / 0.5ml
Accord Healthcare AG
A / SL
FB
G
L
IP
CI
Symdeko 100 mg / 150 mg und 150 mg
56
10544.74
11126.70
10 %
Coated tablets: 2 Active Agents
Coated tablets: Filmtablette Abenddosis (Ivacaftorum 150 Mg): Ivacaftorum 150 mg
Vertex
Pharmaceuticals (CH)
GmbH
A / SL
FB
G
IP
CI
Symtuza
30
919.61
1016.55
10 %
Coated tablets: 4 Active Agents
Janssen-Cilag AG
A / SL
FB
G
L
IP
CI
Verzenios 50 mg
28
988.00
1090.95
10 %
Coated tablets: Abemaciclibum 50 mg
Eli Lilly (Suisse) SA
A / SL
FB
G
L
IP
CI
Verzenios 50 mg
56
1976.00
2165.45
10 %
Coated tablets: Abemaciclibum 50 mg
Eli Lilly (Suisse) SA
A / SL
FB
G
L
IP
CI
Verzenios 100 mg
28
988.00
1090.95
10 %
Coated tablets: Abemaciclibum 100 mg
Eli Lilly (Suisse) SA
A / SL
FB
G
L
IP
CI
Verzenios 100 mg
56
1976.00
2165.45
10 %
Coated tablets: Abemaciclibum 100 mg
Eli Lilly (Suisse) SA
A / SL
FB
G
L
IP
CI
Verzenios 150 mg
28
988.00
1090.95
10 %
Coated tablets: Abemaciclibum 150 mg
Eli Lilly (Suisse) SA
A / SL
FB
G
L
IP
CI
Verzenios 150 mg
56
1976.00
2165.45
10 %
Coated tablets: Abemaciclibum 150 mg
Eli Lilly (Suisse) SA
A / SL
FB
G
IP
CI
Spiriva Respimat 2.5 mcg
29.98
49.00
10 %
Lösung zur Inhalation (wiederverwendbar): Tiotropium 2.5 µg
Boehringer Ingelheim
(Schweiz) GmbH
B / SL
FB
G
IP
CI
Spiriva Respimat 2.5 mcg
3
88.66
112.85
10 %
Lösung zur Inhalation (wiederverwendbar): Tiotropium 2.5 µg
Boehringer Ingelheim
(Schweiz) GmbH
B / SL
FB
G
IP
CI
Striverdi Respimat 2.5 mcg
32.51
51.75
10 %
Lösung zur Inhalation (wiederverwendbar): Olodaterolum 2.5 µg
Boehringer Ingelheim
(Schweiz) GmbH
B / SL
FB
G
IP
CI
Striverdi Respimat 2.5 mcg
3
97.53
122.50
10 %
Lösung zur Inhalation (wiederverwendbar): Olodaterolum 2.5 µg
Boehringer Ingelheim
(Schweiz) GmbH
B / SL
FB
G
IP
CI
Dasatinib-Teva 20 mg
60
PR
PR
k.A.
Coated tablets: Dasatinibum 20 mg
Teva Pharma AG
A
FB
G
IP
Dasatinib-Teva 50 mg
60
PR
PR
k.A.
Coated tablets: Dasatinibum 50 mg
Teva Pharma AG
A
FB
G
IP
Dasatinib-Teva 70 mg
60
PR
PR
k.A.
Coated tablets: Dasatinibum 70 mg
Teva Pharma AG
A
FB
G
IP
Dasatinib-Teva 80 mg
30
PR
PR
k.A.
Coated tablets: Dasatinibum 80 mg
Teva Pharma AG
A
FB
G
IP
Dasatinib-Teva 80 mg
30
PR
PR
k.A.
Coated tablets: Dasatinibum 80 mg
Teva Pharma AG
A
FB
G
IP
Dasatinib-Teva 100 mg
30
PR
PR
k.A.
Coated tablets: Dasatinibum 100 mg
Teva Pharma AG
A
FB
G
IP
Symdeko 50 mg / 75 mg und 75 mg
56
PR
PR
k.A.
Coated tablets: 2 Active Agents
Coated tablets: Filmtablette Abenddosis (Ivacaftorum 75 Mg): Ivacaftorum 75 mg
Vertex
Pharmaceuticals (CH)
GmbH
A
FB
G
IP
CI
Verzenios 200 mg
28
1423.07
1623.85
k.A.
Coated tablets: Abemaciclibum 200 mg
Eli Lilly (Suisse) SA
A
FB
G
IP
CI
Verzenios 200 mg
56
2841.39
3158.40
k.A.
Coated tablets: Abemaciclibum 200 mg
Eli Lilly (Suisse) SA
A
FB
G
IP
Samsca 7.5 mg
10
PR
PR
k.A.
Tablets: Tolvaptanum 7.5 mg
Otsuka Pharmaceutical
(Switzerland) GmbH
B
FB
G
IP
CI
Samsca 15 mg
10
PR
PR
k.A.
Tablets: Tolvaptanum 15 mg
Otsuka Pharmaceutical
(Switzerland) GmbH
B
FB
G
IP
Samsca 30 mg
10
PR
PR
k.A.
Tablets: Tolvaptanum 30 mg
Otsuka Pharmaceutical
(Switzerland) GmbH
B
FB
G
IP
CI
Optifen Dolo Junior 100 mg / 5ml
200 ml
PR
PR
k.A.
Suspension (oral): Ibuprofenum 100 mg
Spirig HealthCare AG
D
FB
G
IP
CI
Kadefemin Estriol Ovula
0.03 mg
20
14.17
28.60
k.A.
Vaginal ovules: Estriolum
Zeller Medical AG
B
FB
G
show caption
Red = Original
CM
= Co-Marketing
EFP = Ex-Factory-Price, exkl. VAT CHF
Green = Generic Drug
V/S
= vaccine/blood product
CP = Consumer Price, inkl. VAT CHF
Black = not classified
A
= Anesthetic
PR = Price request
Gray background = Pending Permission Extension
SIP
= Short Information for Professionals
SB = Selbstbehalt
H
= Homeopathics
IP
= Information for Professionals
DC = Daily Cost
A
= Anthroposophics
CI
= Consumer Information
SL = Official reimbursement list of Switzerland.
Ph
= Phytotherapeutics
L
= Limitations
SO = Original according to SL
Cas Reg.Nr. = CAS Registry
G
= Google Search by Product Name
SG = Generic according to SL
P
= Import parallel
FB
= Drugs Feedback
LPPA = Liste des produits pharmaceutiques pour application spéciale
Legal Disclaimer
ATC-Browser
|
Drugs A-Z
|
Recent Registrations
2025
©ywesee GmbH
Settings
|
Help
|
FAQ
|
Login
|
Contact
|
Home
